Skip to main content
. 2020 Jan 1;12(1):118. doi: 10.3390/nu12010118

Table 2.

Effects of curcumin: in vitro hepatocyte studies.

Cell Curcumin Concentration/Duration Effect Reference
Hepatic stellate cells 30 µM; 2 h ↓ Cell proliferation
↑ Apoptosis
↓ α1(I) collagen, α-SMA and fibronectin mRNA
↑ p21 and p27 protein
↑ Caspase-3 activity
↓ Bcl-2 mRNA
↑ NF-κB activity
[71]
Primary mice isolated hepatocytes 25 µM; 120 min ↓ Hepatic glycogenolysis
↓ Hepatic gluconeogenesis
↓ G6Pase activity
↓ PEPCK activity
↑ Phospho-AMPK
[72]
H4IIE rat hepatoma and Hep3B human hepatoma cells 2–50 µM; 30 min ↓ Hepatic gluconeogenesis
↓ PEPCK activity
↓ G6Pase activity
↑ AMPK activation
[73]
Hepatic stellate cells 0–30 µM; 1 h ↓ HSC activation
↑ HSC apoptosis
↓ PDGF-βR and EGFR
↓ α-SMA and α-II-collagen
↑ PPARγ
↓ Bcl-2
↑ Bax
↓ ROS levels
↑ GSH protein
↑ GSH/GSSG ratio
↑ GCL activity
↓ Phospho-InsR, -ERK1/2, -JNK, -PI3K and -Akt
[74]
Isolated rat hepatocytes 1 and 10 µM; 30 min 1 µM
↓ Lipid peroxidation
↓ Cytochrome c translocation
10 µM
↑ Oxidative stress
↑ Hepatocytoxicity
↑ Necrosis
↑ Apoptosis
↑ Glutathione depletion
↑ Caspase-3 activity
[75]
Rat HSCs and immortalized human hepatocytes 20 µM; 1 h ↓ Glucose levels
↓ GLUT4 membrane translocation
↑ Glucokinase activity
↑ Glucose-6-phosphate levels
↓ Phospho-IRS-1
↓ Phospho-PI3K
↓ Phospho-Akt
[76]
Huh7 cells 20 µM; 48 h ↑ PON1 transactivation
↑ PON1 mRNA and protein
[77]
L02 hepatocytes - ↓ Oxidative stress
↓ Insulin resistance
↓ ROS production
↓ Glutathione depletion
↓ MDA levels
↓ LDH activity
↓ AST activity
[78]
Primary rat hepatocytes 10 µM; 12 h ↓ Lipo-apoptosis
↓ ROS production
↓ ATP depletion
↓ PEPCK levels
↓ G6Pase levels
↑ Mitochondrial DNA
↑ PGC1α, NRF1 and Tfam mRNA
↑ MMP
↓ NF-kB p65 mRNA
[79]
AML-12 cells 50 µM; 2 h ↑ Insulin response
↑ Phospho-PKB
↓ ROS levels
↓ MDA levels
↓ Phospho-JNK
↓ Phospho-p38
[80]
Primary rat hepatocytes 15 µM; 24 h ↓ Lipid formation
↑ APOBEC-1 mRNA and protein
↑ ApoB mRNA editing
↓ Apo-B lipid formation
[81]
HepG2 cells 30 µM; 2 h ↓ Cholesterol cell content
↓ Endosome/lysosome size and localization
↑ Cholesterol β-hexosaminidase enzyme level
↑ Lysosomal β-hexosaminidase enzyme level
↑ Flotillin-2-positive granules
↑ CD63-positive granules
[82]
HepG2 cells 5–20 µM; 24 h ↑ Hypolipidemic activity
↑ LDL uptake
↑ LDL receptor expression
↑ LDL receptor activity
↓ PCSK9 mRNA and protein
↓ PCSK9 promoter activity
↓ HNF-1α mRNA and protein
↓ HNF-1α nuclear promoter
[83]
L02 cells 2.5 and 5 µM; 2 h ↓ Oxidative stress
↑ Cell viability
↓ DNA-fragments
↓ Micronuclei formation
↓ ROS production
↑ SOD activity
↑ GSH levels
[84]
Primary mice hepatocytes 25 µM; 6 h ↓ Glucose production
↑ FGF21 protein
↑ Phospho-Akt
[85]
L02 cells 5 µM; 2 h ↓ QCT-induced inflammatory response
↓ QCT-induced oxidative stress
↓ Mitochondrial dysfunction
↓ Apoptosis
↓ iNOS activity
↓ NO production
↓ NF-κB mRNA
↑ Nrf2 and HO-1 mRNA
[86]
HepG2 cells 30 µM; 24 h ↓ Hepatic steatosis
↑ Leptin resistance
↓ Lipid deposition
↓ SREBP-1c, SCD-1 and CD36 mRNA
↑ ACC, ACOX1, CPT-1 and PPARα mRNA
↑ Phospho-AMPK
↑ Phospho-ACC
[87]
Primary mouse hepatocytes 1 µM; 4 h ↑ Lipogenesis
↑ ChREBP activation
↑ ChREBP mRNA
↑ Lpk, Fas, Acc1, Scd1 and Me1 mRNA
↑ ChREBP-LUC activity
↓ Oct-1-ChREBP binding
[88]
HepG2 and primary mouse hepatocytes 2 µM; 6 h ↓ Fgf21 resistance
↑ Fgf21 activity
↑ Fgf21 mRNA
↑ PPARα mRNA
↑ Fgf21-LUC activity
↑ PPARα-Fgf21 binding
[89]
HepG2 cells 5 µM; 5 days ↓ Insulin resistance
↑ Glucose consumption
↓ Oxidative stress
↑ Phospho-IR
↑ Phospho-Akt
↓ MDA levels
↓ IL-6 levels
↓ TNF-α levels
↓ Phospho-JNK and p38
↓ Phospho-IKKβ and IκB-α
[90]
Human LX-2 HSCs 40 µM; 24 h ↓ Fibrotic myofibroblastic phenotype
↑ Lipocyte phenotype
↑ Lipid droplet abundance
↑ Lipid metabolism
↑ Triglyceride content
↑ Nrf2 protein and nuclear translocation
↑ C/EBPα, PPARγ, RXRα and RXRβ protein
↓ PPARα protein
[91]
Primary mice hepatocytes 10 µM; 24 h ↓ Palmitate-induced steatosis
↑ CYP7A and CYP3A protein
↓ SREBP-1c protein
[92]
HepG2 cells and primary mice hepatocytes 10 µM; 30 and 120 min ↓ Glucose production
↓ Mitochondrial complex I activity
↓ cAMP accumulation
↑ PDE4B induction
↑ Phospho-AMPK
↓ Acetyl CoA accumulation
↓ PDK4 mRNA
↓ PDH activity
↓ PC protein
[93]
BRL-3A and HepG2 cells 2.5 µM; 8 and 12 h ↓ Fructose-induced inflammation
↓ NLRP3 inflammasome activity
↑ miR-200a level
↓ NLRP3 and ASC protein
↓ Caspase-1 and IL-1β protein
↓ TXNIP protein
↓ ROS production
↓ H2O2 levels
[94]
HepG2 cells 10 µM; 24 h ↓ Lipotoxicity
↓ Lipid vacuole accumulation
↓ ROS production
↓ SREBP-1, PPAR-γ2 and PARP levels
↓ Cleaved caspase 3 levels
[95]
HepG2 cells 10 µM; 1 h ↓ Palmitate-induced inflammatory injury
↓ Palmitate-induced fibrosis
↓ TNF-α, IL-6, IL-1β and COX-2 mRNA
↓ ICAM, VCAM-1 and MCP-1 mRNA↓ α-SMA, COL-1, COL-4 and TGF-β mRNA
↓ α-SMA protein
[96]